Skip to content

Thoracic Spinal Manipulation in Stroke

Effects of Thoracic Spinal Manipulation on Balance, Fall Risk, and Thoracic Mobility in Patients With Chronic Stroke: A Randomized Crossover Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07436975
Enrollment
52
Registered
2026-02-27
Start date
2026-03-16
Completion date
2026-05-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Balance

Brief summary

The aim of the study is to investigate the effects of thoracic spinal manipulation on balance, fall risk, and thoracic mobility of the patients with chronic stroke.

Detailed description

The study, utilizing a randomized crossover design, is planned to be conducted on a minimum of 26 patients with stroke who meet the inclusion and exclusion criteria. Patients included in the study will be randomly assigned to receive both placebo thoracic spinal manipulation and thoracic spinal manipulation interventions.

Interventions

This technique is based on the application of a high-velocity, low-amplitude force to the thoracic spine with the aim of increasing thoracic mobility.

OTHERPlacebo Thoracic Spinal Manipulation

This intervention is a classic method used to evaluate the effect of thoracic spinal manipulation.

Sponsors

Bitlis Eren University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The evaluator and the researcher administering the intervention will be different. The interventions will be administered to participants randomly.

Intervention model description

The patients enrolled in the study will receive placebo thoracic spinal manipulation and thoracic spinal manipulation in a randomized sequence. The order of the interventions will be determined by flipping a coin.

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Having chronic stroke, * A Mini-Mental State Examination score of 24 or higher, * Ability to stand independently for 20 seconds or more, * Ability to walk independently for 10 meters, using assistive devices or orthoses if necessary, * Being between 40 and 75 years of age, * Having a Brunnstrom stage of 4 or above

Exclusion criteria

* History of whiplash injury, * Diagnosis of fibromyalgia, * History of spinal manipulation treatment within the previous 2 months, * History of cervical or thoracic fracture or dislocation, * History of cervical or thoracic spine surgery, * Diagnosis of cervical radiculopathy or myelopathy, * Presence of serious spinal pathology, * Presence of any orthopedic or neurological disorder other than stroke, or an unstable cardiac condition, * Presence of a vestibular disorder, * The presence of lower extremity ulceration or amputation, * Alcohol consumption in the last 24 hours, * Posterior circulation stroke involving the basilar artery or cerebellum, * Having experienced an acute lower extremity injury in the last six weeks, * History of lower extremity surgery

Design outcomes

Primary

MeasureTime frameDescription
Overall Postural Stability Index MeasurementChange from baseline overall postural stability index immediately after the interventionThis index will be assessed by measuring deviations of the center of gravity in the anteroposterior and mediolateral directions. Lower scores indicate smaller deviations and better postural stability. The test will be performed on a stable platform with two trials of 30 seconds each. The average of the three trials will be automatically calculated by the TechnoBody balance system.
Fall Risk AssessmentChange from baseline overall postural stability index immediately after the interventionFall risk will be assessed by measuring the patient's ability to maintain balance on an unstable platform. Based on their ability to maintain balance, a fall risk score will be generated, with higher scores indicating a greater risk of falling. The test will be performed with two 30-second trials. The average of the three trials will be calculated automatically by the TechnoBody balance system.

Secondary

MeasureTime frameDescription
Anteroposterior Stability Index MeasurementChange from baseline overall postural stability index immediately after the interventionThe anteroposterior stability index will be assessed by measuring deviations of the center of gravity in the anteroposterior direction. Lower scores indicate smaller deviations and better anteroposterior postural stability. The test will be performed on a stable platform with two trials of 30 seconds each. The average of the three trials will be automatically calculated by the TechnoBody balance system.
Mediolateral Stability Index MeasurementChange from baseline mediolateral stability index immediately after the interventionThe mediolateral stability index will be assessed by measuring deviations of the center of gravity in the mediolateral direction. Lower scores indicate smaller deviations and better mediolateral postural stability. The test will be performed on a stable platform with two trials of 30 seconds each. The average of the three trials will be automatically calculated by the TechnoBody balance system.
Thoracic MobilityChange from baseline mediolateral stability index immediately after the interventionThoracic mobility will be assessed by measuring trunk rotation and lateral flexion using a smartphone inclinometer positioned at the level of T2.

Countries

Turkey (Türkiye)

Contacts

CONTACTömer dursun, Asst. Prof.
fztomrdrsn@gmail.com5426088687
CONTACTburak mavuş, M.Sc.
a.burakmavus@gmail.com5388178351
PRINCIPAL_INVESTIGATORömer dursun, Asst. Prof.

Bitlis Eren University

PRINCIPAL_INVESTIGATORburak mavuş, M.Sc.

Bolu Abant İzzet Baysal Physiotherapy and Rehabilitation Training and Research Hospital

PRINCIPAL_INVESTIGATORmerve tunçdemir, Asst. Prof.

Bitlis Eren University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026